Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
60
NCT03237832
A Phase 1 Study of ARN-6039
Phase: Phase 1
Role: Lead Sponsor
Start: May 16, 2016
Completion: Feb 28, 2017